Plasma Protein Therapeutics Association




about PPTA
The Plasma Protein Therapeutics Association (PPTA) is a key player in the plasma industry, with an extensive network of human plasma collection centers and manufacturers. Collaborating with numerous key stakeholders and policymakers to establish rightful standards and programs for donors and patients is at the core of our work.


Why you should donate plasma
Plasma-derived medicines are often the only therapies for many rare and chronic diseases. By becoming a donor, you increase the chances of regular access to plasma medicines for those in need, contributing to the improvement of health outcomes for patients.






Resource centER
Learn more about our work through the material in our resource center.

Media
Stay up to date with the key developments and issues discussed by our stakeholders, members, and patients by taking a look at our available media resources.

Watch our interview with Prof. Richard Knight as he shares valuable perspectives on immunoglobulins

Patient Stories presented by PPTA

PPTA New Website and Brand Launch

The Brussels Times Hosts Event at the European Parliament

Take a tour of a plasma donation center in Frankfurt, Germany

The need for a policy change – Plasma donation
-%20Day%20One.jpg)
2022 International Plasma Protein Congress (IPPC): Day One
-%20Day%20One.jpg)
2022 International Plasma Protein Congress (IPPC): Day Two

Differentiating Plasma from Blood

U.S. Roundtable on Immunoglobulin Use

EU BTC revision – The socioeconomic benefits of plasma-derived medicines

Why is Donating Plasma Important?

Strengthening the EU Blood Directive for patients who need plasma-derived medicines

Meet Amber, a Teacher and Dedicated Plasma Donor

Europe needs to collect more plasma – Improving patient access to plasma-derived medicines

EU BTC revision – Facts about compensating plasma donors
.jpg)
Highlights from the April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)
.jpg)
April 2021 Online Roundtable hosted by MEP Sirpa Pietikäinen (EPP, Finland)

“Introduction to the Global Journey of Plasma" webinar

Presentation of the 2020 Joachim Hilfenhaus Award

Presentation of the 2020 Robert W. Reilly Award

Highlights from the EP roundtable event “Ensuring Appropriate Patient Access to PDMPs”

Keynote Address – Admiral Brett Giroir, MD, U.S. HHS Assistant Secretary for Health

Experts on Coronavirus: The Virus, The Disease, Prevention and Treatment

Combating COVID-19 Industry Spotlight: Kedrion

Keynote Address – Stella Kyriakides, European Commissioner for Health and Food Safety

Plasma: An Overview

Patient Perspectives on COVID-19 and Access to Care

Welcome to the Global Plasma Summit

Combating COVID-19 Industry Spotlight: CoVIg-19 Plasma Alliance

Combating COVID-19 Industry Spotlight: Grifols

Plasma 101

Combating COVID-19 Industry Spotlight: Emergent

Spotlight on Plasma Part One: Together We Are Stronger

Ensuring Appropriate Patient Access to Plasma-Derived Medicinal Products

PPTA webinar on unique patient access challenges to plasma-derived medicinal products in COVID times link

Thank you, plasma donors!

From PPTA: "Thank you, plasma donors!"

Prof. Lieven Annemans Speaks about the Value of Plasma-Derived Therapies

The Power of Plasma Donation - Hungarian

The Power of Plasma Donation - Spanish

The Power of Plasma Donation - Czech

The Power of Plasma Donation - German
.jpg)
The Power of Plasma Donation Animation - English
PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

PPTA Statement on the Revision of the General EU Pharmaceutical Legislation

Announcing PPTA’s New Global Chair

Announcing PPTA’s New Global Chair
Monkeypox Virus and Plasma Protein Therapies

Monkeypox Virus and Plasma Protein Therapies
PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report

PPTA Executive Summary of FDA’s U.S. Immunoglobulin Utilization Study Report
PPTA Statement on Review of Donor Blood Pressure Requirements

PPTA Statement on Review of Donor Blood Pressure Requirements
PPTA Statement on Review of Donor Weight Loss Monitoring

PPTA Statement on Review of Donor Weight Loss Monitoring
Statement on Update on Safety of Albumin

Statement on Update on Safety of Albumin
PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses

PPTA Statement on Safety of Plasma Protein Therapies and the H5N1 Viruses
Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus

Statement on the Safety of Plasma Protein Therapies and Swine Influenza Virus
Human Parvovirus PARV4 and plasma protein therapies

Human Parvovirus PARV4 and plasma protein therapies
Ebola Virus and Plasma Protein Therapies

Ebola Virus and Plasma Protein Therapies
PPTA Statement on MSM Donor Policy

PPTA Statement on MSM Donor Policy
Zika Virus and Plasma Protein Therapies

Zika Virus and Plasma Protein Therapies
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
.jpg)
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”

PPTA Statement on “How Blood-Plasma Companies Target the Poorest Americans”
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
%20and%20the%20Safety%20Margins%20of%20Plasma%20Protein%20Therapies.jpg)
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies
A Note to U.S. Plasma Donors on the Spread of Coronavirus

A Note to U.S. Plasma Donors on the Spread of Coronavirus
PPTA Responds to The Guardian Article

PPTA Responds to The Guardian Article
PPTA Statement on FDA Guidance Documents

PPTA Statement on FDA Guidance Documents
PPTA Repeats Appeals for Plasma Donations

PPTA Repeats Appeals for Plasma Donations
New York and California recognize the importance of plasma donation

New York and California recognize the importance of plasma donation
Plasma Donors Should be Celebrated, not Denigrated

Plasma Donors Should be Celebrated, not Denigrated
PPTA Statement on the Urgent Need for Plasma Donation

PPTA Statement on the Urgent Need for Plasma Donation
PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act

PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act
Yes, you can donate source plasma after getting the COVID vaccine

Yes, you can donate source plasma after getting the COVID vaccine
PPTA Statement on Immunoglobulin Use to Meet Clinical Need

PPTA Statement on Immunoglobulin Use to Meet Clinical Need
Human Plasma Donations Remain Important During COVID-19 Pandemic

Human Plasma Donations Remain Important During COVID-19 Pandemic
New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs

New position statement by CHMP regarding donor deferral criteria for sexual behaviour helps assessment of PMFs
Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID

Study Shows Immunoglobulin Therapy is “Critical and Cost-Effective” in Treating COVID
PPTA Responds to ProPublica Article

PPTA Responds to ProPublica Article
Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives
PPTA Disagrees with Ruling from Romanian Competition Council

PPTA Disagrees with Ruling from Romanian Competition Council
PPTA Leadership Update – Amy Efantis

PPTA Leadership Update – Amy Efantis
PPTA Statement on the Ukraine Crisis

PPTA Statement on the Ukraine Crisis
PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation

PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation
PPTA Statement on the draft EU Substances of Human Origin Regulation

PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA Letter to Stakeholders re: European Data Program Update

PPTA Letter to Stakeholders re: European Data Program Update
PPTA Recognizes First Plasma Collection Centers Certified in Hungary

PPTA Recognizes First Plasma Collection Centers Certified in Hungary
PPTA Recognizes World Hemophilia Day 2014

PPTA Recognizes World Hemophilia Day 2014
International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases

International Plasma Awareness Week to Celebrate Donors and Spotlight Rare Diseases
Ensuring Access to Medicines for Patients

Ensuring Access to Medicines for Patients
PPTA Recognizes 8th Annual International Rare Disease Day

PPTA Recognizes 8th Annual International Rare Disease Day
PPTA Recognizes World Hemophilia Day–April 17, 2015

PPTA Recognizes World Hemophilia Day–April 17, 2015
Alabama Lowers Minimum Donation Age to 18

Alabama Lowers Minimum Donation Age to 18
PPTA Recognizes Essential Contributions of Plasma Donors

PPTA Recognizes Essential Contributions of Plasma Donors
PPTA Names Amy Efantis President & CEO

PPTA Names Amy Efantis President & CEO
Plasma-Derived Therapies Provide Significant Health Value Gain

Plasma-Derived Therapies Provide Significant Health Value Gain
EU Health Commissioner Says Plasma Donation is “More Important Than Ever”

EU Health Commissioner Says Plasma Donation is “More Important Than Ever”
International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today

International Plasma Awareness Week 2020: Be a Hero, Donate Plasma Today
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma

Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients

Lifting of long-time ban on use of UK plasma for manufacturing of immunoglobulins will help patients
EU Health Commissioner says plasma donation plays a vital role

EU Health Commissioner says plasma donation plays a vital role
International Plasma Awareness Week 2021: Donate Plasma. Save Lives.

International Plasma Awareness Week 2021: Donate Plasma. Save Lives.
Calling on EU Policymakers to Increase Plasma Donations

Calling on EU Policymakers to Increase Plasma Donations
Adoption of the EP report “EU Pharmaceutical Strategy”

Adoption of the EP report “EU Pharmaceutical Strategy”

Plasma is Life podcast series episode 6: Peter Jaworski, Georgetown University

Plasma is Life podcast series episode 5: Nancy Di Salvo, GBS|CIDP Foundation

Plasma is Life podcast series episode 4: Vicki & Fred Modell, Co-Founders, Jeffrey Modell Foundation

Plasma is Life podcast series episode 2: U.S. Election 2020 Wrap-Up
Events
National Hemophilia Foundation (NHF) Bleeding Disorders Conference
HAE Day :-)
Join PPTA
Become a member of PPTA! PPTA engages with stakeholders to establish and improve regulations and policies that affect the sector.
By being a member of our industry-leading association, you can work closely with influential partners, enjoy numerous benefits and access useful resources.
Contact us
If you have any inquiries, get in touch with us by filling out our contact form.